. Pseudoratiometric imaging of calcium influx shows that Fluo-4 intensity rise is caused by Ca 2+ concentration increase, not shape change of the cell. Time course of Fluo-4 intensity (green) and Fura-Red intensity (red) and ratio of Fluo-4 to Fura-Red intensity (blue) for T cells continuously contacted with anti-CD3-coated tip (A) and control mAb-coated tip (hCD25; B). (C) Pulling forces become maximal at a low integrated Ca 2+ flux. All touches shown use an anti-CD3-coated cantilever and also appear elsewhere in this article. A linear fit is given for each condition: T cells treated with the CRAC inhibitor 2-APB (green), the calcium chelator EGTA (blue), or control treatment (red). A local regression scatterplot smoothing (LOE SS) curve is shown (blue) spanning all the data points with CI of fit (light blue). At an integrated Ca 2+ higher than ∼200, the pulling force becomes near-maximal. Figure S3 . Application of cyclic force in the absence of LatA does not significantly increase signaling strength compared with continuous contact. (A) Time courses of both force on the cantilever and normalized Fluo-4 intensity during application of cyclical forces using pMHC-coated cantilevers in the absence of LatA. (B) Time-integrated calcium flux for T cells stimulated using pMHC-coated tips, using either continuous contact or cyclic force. Each dot is one T cell contacted. Data for the continuous contacts were the same LatA-treated cells in Fig. 4 . Application of cyclic force with control-coated cantilevers does not rescue force or calcium flux in LatA-treated T cells. (C-F) Time courses of both force on the cantilever and normalized Fluo-4 intensity during application of cyclical forces for LatA-treated cells and control-coated cantilevers, either anti-hCD25 coated (C) or anti-CD43 coated (D). Amplitude of force oscillations over time during application of cyclical forces for LatA-treated cells and control-coated cantilevers, either anti-hCD25 coated (E) or anti-CD43 coated (F).
